Stagnating Life Expectancy: A Regional Crisis in Europe and the US

For over a century and a half, life expectancy in wealthy nations has consistently increased, driven by declines in infectious diseases and advancements in cardiovascular medicine. However, recent gains have slowed significantly in several Western countries, prompting questions about whether human longevity is approaching its limits.

The Widening Gap: US and Europe

While overall life expectancy has improved globally, a concerning trend has emerged: a stagnation in gains, particularly in the United States. Reductions in U.S. Cardiovascular disease (CVD) mortality have stalled, lagging behind other high-life-expectancy countries [1]. Between 2008 and 2019, the gap in life expectancy between the U.S. And other high-income countries grew substantially, with cardiovascular disease playing a significant role [2].

A New European Study: Regional Disparities

A recent study published in Nature Communications analyzed data from 450 regions across 13 Western European countries (including Spain, Denmark, Portugal, and Switzerland) between 1992 and 2019. This large-scale analysis revealed significant regional variations in longevity trajectories.

Human Longevity Has Not Reached Its Limits

The study found that regions with consistently high life expectancy continue to see gains of approximately 2.5 months per year for men and 1.5 months per year for women, at rates comparable to previous decades. These regions include areas in Northern Italy, Switzerland, and parts of Spain, as well as regions surrounding Paris, France.

Regional Divergence Since the Mid-2000s

However, regions with lower life expectancy experienced rapid gains in the 1990s and early 2000s, leading to convergence across Europe. This “golden age” ended around 2005. In areas like East Germany, Wallonia in Belgium, and parts of the United Kingdom, life expectancy gains have stalled. This has created a growing disparity between regions that continue to progress and those where gains have stagnated or reversed.

The Role of Mortality Between Ages 55-74

The study pinpointed a critical factor driving this divergence: mortality rates between the ages of 55 and 74. While infant mortality remains low and mortality after age 75 continues to decelerate, mortality in this intermediate age range has develop into a key determinant of overall life expectancy gains. Improvements in cardiovascular treatments and risk-taking behaviors in the 1990s led to a rapid decline in mortality around age 65, but this trend has slowed since the 2000s. In some regions, mortality between 55 and 74 is now increasing.

Underlying Factors and Future Outlook

While the study doesn’t definitively identify the causes of increasing mortality between 55 and 74, potential factors include lifestyle choices such as smoking, alcohol consumption, poor nutrition, and lack of physical exercise. Economic downturns, like the 2008 financial crisis, have too exacerbated regional disparities. These factors highlight that longevity is influenced not only by medical advancements but also by social and economic conditions.

The findings suggest that increasing life expectancy is possible, as demonstrated by leading regions in Europe. However, progress is not universal, and a rise in mortality around age 65 threatens to widen the gap between thriving and lagging regions. The future of human longevity may depend on addressing these regional disparities and reducing inequalities in health outcomes.